Gsk Consumer Health, Inc.

Location

New Jersey

Founded

1994-02-28

Risk Signals

9279 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Gsk Consumer Health, Inc.

Live alerts from global media, monitored by Business Radar

Record numbers of UK Anti-Doping whistleblowers come forward

2025-01-28 (cityam.com)

Record numbers of UK Anti-Doping whistleblowers come forward

Whistleblower numbers for suspected sports doping are at a record high in the United Kingdom, according to UK Anti-Doping (UKAD).

Read more
Unpacking the ‌Requip Controversy: GSK’s Legal Battle and the Call for Pharmaceutical Openness

2025-01-17 (world-today-news.com)

Unpacking the ‌Requip Controversy: GSK’s Legal Battle and the Call for Pharmaceutical Openness

GSK Faces ⁢Legal ​Battle Over Requip side Effects: A Deep Dive into ‍the Controversy In a landmark case that ⁣has reignited concerns about pharmaceutical openness, GlaxoSmithKline ‍(GSK) is being sued by stéphane Grange, a 50-year-old Parkinson’s‍ patient who claims he suffered severe⁣ side effects after using Requip (ropinirole). the lawsuit, filed on February 15,⁣ 2024, ... Read more

Read more
Unpacking the ‌Requip Controversy: GSK’s Legal Battle and the Call for Pharmaceutical Openness

2025-01-17 (world-today-news.com)

Unpacking the ‌Requip Controversy: GSK’s Legal Battle and the Call for Pharmaceutical Openness

GSK Faces ⁢Legal ​Battle Over Requip side Effects: A Deep Dive into ‍the Controversy In a landmark case that ⁣has reignited concerns about pharmaceutical openness, GlaxoSmithKline ‍(GSK) is being sued by stéphane Grange, a 50-year-old Parkinson’s‍ patient who claims he suffered severe⁣ side effects after using Requip (ropinirole). the lawsuit, filed on February 15,⁣ 2024, ... Read more

Read more
Unpacking the ‌Requip Controversy: GSK’s Legal Battle and the Call for Pharmaceutical Openness

2025-01-17 (world-today-news.com)

Unpacking the ‌Requip Controversy: GSK’s Legal Battle and the Call for Pharmaceutical Openness

GSK Faces ⁢Legal ​Battle Over Requip side Effects: A Deep Dive into ‍the Controversy In a landmark case that ⁣has reignited concerns about pharmaceutical openness, GlaxoSmithKline ‍(GSK) is being sued by stéphane Grange, a 50-year-old Parkinson’s‍ patient who claims he suffered severe⁣ side effects after using Requip (ropinirole). the lawsuit, filed on February 15,⁣ 2024, ... Read more

Read more
Cambridge University partners with scandal hit drug manufacturers

2024-10-25 (varsity.co.uk)

Cambridge University partners with scandal hit drug manufacturers

The pharamaceutical giant was recently sued over claims its heartburn drug caused cancer

Read more
How the Zantac Litigation Went Sour

2024-10-24 (acsh.org)

How the Zantac Litigation Went Sour

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions - with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit brought by Valisure, the private laboratory that instigated the personal injury litigation and

Read more
GSK Tab To Clear Zantac Litigation Ledger Of 93% Of Complaints Pending In State Courts: $2.2Bn

2024-10-09 (citeline.com)

GSK Tab To Clear Zantac Litigation Ledger Of 93% Of Complaints Pending In State Courts: $2.2Bn

UK pharma also reaches agreement in principle, subject to DoJ approval, to pay $70m to resolve a whistleblower complaint filed by Valisure, the testing lab which in 2019 raised concerns about a potential link between the use of drugs containing ranitidine, a histamine-2 blocker, and cancer.

Read more
Zantac Scandal Haunts GSK - Cancer Trials Coming, Shares Plunge -10%

2024-06-03 (bankingnews.gr)

Zantac Scandal Haunts GSK - Cancer Trials Coming, Shares Plunge -10%

Zantac Scandal Haunts GSK - Cancer Trials Coming, Shares Plunge -10%

Read more
Whistleblower Claims GlaxoSmithKline Lied to FDA, Federal Government About Zantac Safety Claims

2024-05-21 (vcpost.com)

Whistleblower Claims GlaxoSmithKline Lied to FDA, Federal Government About Zantac Safety Claims

A whistleblower has come out with allegations that GlaxoSmithKline (GSK) deceived the public about the safety of Zantac, a popular heartburn medicine.

Read more
Whistleblower Claims GlaxoSmithKline Lied to FDA, Federal Government About Zantac Safety Claims

2024-05-21 (vcpost.com)

Whistleblower Claims GlaxoSmithKline Lied to FDA, Federal Government About Zantac Safety Claims

A whistleblower has come out with allegations that GlaxoSmithKline (GSK) deceived the public about the safety of Zantac, a popular heartburn medicine.

Read more
The historical scandal of the American pharmaceutical giant

2024-05-13 (khabarfarsi.com)

The historical scandal of the American pharmaceutical giant

Revelations about the carcinogenicity of one of the most common over-the-counter drugs have taken Pfizer, one of the largest multinational pharmaceutical and biotech companies, in its grip.

Read more
Detective hired by GlaxoSmithKline jailed for spying in China

2014-08-08 (theguardian.com)

Detective hired by GlaxoSmithKline jailed for spying in China

Peter Humphrey and wife, who had been hired by drug firm GlaxoSmithKline, jailed over illegal obtaining of information

Read more

Never miss a headline about Gsk Consumer Health, Inc.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages